Research graph
References from Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (Sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2004 · External reference
10.1001/jama.280.11.969
10.1001/jama.280.11.969 · 1998 · External reference
10.1200/jco.1999.17.5.1499
10.1200/jco.1999.17.5.1499 · 1999 · External reference
10.1016/s0022-5347(05)66349-5
10.1016/s0022-5347(05)66349-5 · 2001 · External reference
10.1016/s0022-5347(17)32397-2
10.1016/s0022-5347(17)32397-2 · 1994 · External reference
